✦ LIBER ✦
The human complement receptor type 2/factor H fusion protein TT30, an alternative pathway specific complement inhibitor, prevents hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria by membrane-targeting of factor H activity
✍ Scribed by Antonio M. Risitano; Caterina Pascariello; Carmine Selleri; Luigi Del Vecchio; Michela Sica; Masha Fridkis-Hareli; Istvan Mazsaroff; Christopher J. Horvath; V. Michael Holers
- Book ID
- 116757688
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 71 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0161-5890
No coin nor oath required. For personal study only.